bms-906024
chemical compound
Q15408421Snapshot
≈ 1 min read
Names in other languages
- Englishbms-906024
- ItalianoBMS-906024
- shBMS-906024
- СрпскиBMS-906024
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as a pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330130981 under CC BY-SA 4.0; modifications have been made.